Dr. Agarwal’s Health Care Ltd (AHCL) on Tuesday said that its Scheme of Amalgamation with Dr. Agarwal’s Eye Hospital Ltd (AEHL) has become effective and operative from November 1.
NCLT, Chennai Bench, sanctioned the Scheme through an order dated September 30, 2026. Following other procedures, the amalgamation has taken effect, AHCL said.
The amalgamation brings the two listed entities together within Dr. Agarwal’s Health Care Ltd, simplifying the Group’s corporate structure as it continues to expand its eye-care network. The combined structure provides a more unified framework for governance, capital allocation and long-term business planning.
The Board has fixed Wednesday, November 18, 2026 as the record date for determining eligible shareholders of Dr. Agarwal’s Eye Hospital Ltd who will receive shares of Dr. Agarwal’s Health Care Ltd pursuant to the Scheme.
The consolidation will help support closer alignment across investments in hospitals, clinical capabilities, technology and talent, while providing shareholders and investors with a clearer view of the combined organisation.
“Our focus remains on creating long-term value through disciplined expansion, stronger operating performance and continued investment in clinical excellence. We believe the combined structure will support greater organisational alignment as we scale across markets,” Adil Agarwal, Chief Executive Officer, Dr. Agarwal’s Health Care Ltd said.
Under the approved share exchange ratio, eligible AEHL shareholders will receive 23 fully paid-up equity shares of AHCL of face value ₹1 each for every 2 fully paid-up equity shares of AEHL of face value ₹10 each held. This is equivalent to 11.5 AHCL shares for every one AEHL share.
Published on November 17, 2026




